Zobrazeno 1 - 10
of 41
pro vyhledávání: '"C M, Pinsky"'
Autor:
N. J. Petrelli, Y. Z. Patt, L Hammershaimb, Frederick L. Moffat, F. S. Whaley, C. M. Pinsky, David M. Goldenberg
Publikováno v:
Journal of Clinical Oncology. 14:2295-2305
PURPOSE To assess the performance and the potential clinical impact of a new antibody imaging agent, CEA-Scan (Immunomedics Inc, Morris Plains, NJ), in 210 presurgical patients with advanced recurrent or metastatic colorectal carcinomas. METHODS CEA-
Autor:
M J, Blend, H, Hyun, M, Kozloff, H, Levi, G Q, Mills, M, Gasparini, G, Buraggi, L, Hughes, C M, Pinsky, D M, Goldenberg
Publikováno v:
Cancer research. 55
Radioimmunodetection (RAID) with the 99mTc-labeled Fab' fragment of monoclonal antibody (MoAb) LL2 has been reported to have a high lesion detection rate for malignant lymph nodes as well as for visceral and skeletal tumor masses (20). Our purpose in
Autor:
C H, Ewel, W J, Urba, W C, Kopp, J W, Smith, R G, Steis, J L, Rossio, D L, Longo, M J, Jones, W G, Alvord, C M, Pinsky
Publikováno v:
Cancer research. 52(11)
We have performed a phase IB study of polyinosinic-polycytidylic acid complexed with poly-L-lysine and carboxymethylcellulose (poly-ICLC) in combination with interleukin 2 (IL-2) in 25 patients with a variety of cancers. Patients received weekly or b
Publikováno v:
Nuclear Medicine Communications. 18:461
Publikováno v:
Nuclear Medicine Communications. 17:261
Publikováno v:
Nuclear Medicine Communications. 17:285
Publikováno v:
Clinical Nuclear Medicine. 17:525
Autor:
David M. Goldenberg, R. E. Lee, S. Murthy, H. J. Hansen, J. Barcelo, C. M. Pinsky, Robert M. Sharkey
Publikováno v:
Journal of Immunotherapy. 11:136
Autor:
G. Y. Wong, P. Gascon, C. M. Pinsky, Jeffry A. Siegel, David M. Goldenberg, Robert M. Sharkey, H. J. Hansen, S. Murthy, M. Vezza, D O Izon
Publikováno v:
Journal of Immunotherapy. 11:144
Publikováno v:
Cancer. 60(3)
Toxicity of bacillus Calmette-Guerin (BCG) Pasteur strain, given in a dose of 120 mg once a week for 6 weeks, was retrospectively evaluated in a study of 107 patients with recurrent superficial bladder cancer. Only six patients had no symptoms of tox